Literature DB >> 22302503

MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis.

Tobias Heye1, Schu-Ren Yang, Michael Bock, Sylvia Brost, Kilian Weigand, Thomas Longerich, Hans-Ulrich Kauczor, Waldemar Hosch.   

Abstract

OBJECTIVES: To evaluate hepatic relaxation times T1, T2 and T2* in healthy subjects and patients with liver cirrhosis stratified by the Child-Pugh classification (CPC).
METHODS: Sixty-one consecutive patients were stratified by CPC (class A026; B020; C015) and compared with age-matched controls (n = 31). Relaxometry measurements were performed at 1.5 T using six saturation recovery times (200-3,000 ms) to determine liver T1, six echo times (TE 14-113 ms) for T2 and eight TE (4.8-38 ms) for T2* assessment. Signal intensities in selected regions of interest in the liver parenchyma were fitted to theoretical models with least squares minimisation algorithms to determine T1, T2 and T2*.
RESULTS: The most significant difference was the higher T1 values (852 ± 132 ms) in cirrhotic livers compared with controls (678 ± 45 ms, P < 0.0001). A less significant difference was seen for T2* (23 ± 5 vs. 26 ± 7 ms). Subdifferentiation showed a statistically significant difference between control group and individual CPC classes as well as between class C and classes A or B for T1 relaxation times.
CONCLUSION: Measurement of T1 relaxation time can differentiate healthy subjects from patients with liver cirrhosis, and can distinguish between mild/moderate disease (CPC A/B) and advanced disease (CPC C). KEY POINTS: • Significantly elevated magnetic resonance T1 relaxation times are found in liver cirrhosis. • T1 relaxation times can distinguish healthy subjects from patients with liver cirrhosis. • T1 relaxation times can distinguish Child-Pugh classes Aand B from C.

Entities:  

Mesh:

Year:  2012        PMID: 22302503     DOI: 10.1007/s00330-012-2378-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  35 in total

1.  Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones.

Authors:  Seung Up Kim; Kwang-Hyub Han; Sang Hoon Ahn
Journal:  J Gastroenterol Hepatol       Date:  2010-09       Impact factor: 4.029

2.  MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver.

Authors:  Samiullah Shaikh; Hanif Ghani; Sadik Memon; Ghulam Hussain Baloch; Mukhtiar Jaffery; Khalid Shaikh
Journal:  J Coll Physicians Surg Pak       Date:  2010-07       Impact factor: 0.711

3.  Multi-center trial with protocols and prototype test objects for the assessment of MRI equipment. EEC Concerted Research Project.

Authors:  R A Lerski; D W McRobbie; K Straughan; P M Walker; J D de Certaines; A M Bernard
Journal:  Magn Reson Imaging       Date:  1988 Mar-Apr       Impact factor: 2.546

4.  In vivo field dependence of proton relaxation times in human brain, liver and skeletal muscle: a multicenter study.

Authors:  O Henriksen; J D de Certaines; A Spisni; M Cortsen; R N Muller; P B Ring
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

5.  Multiple NMR T2 relaxation values in human liver tissue.

Authors:  M E Bernardino; W Small; J Goldstein; C W Sewell; P J Sones; K Gedgaudas-McClees; J T Galambos; J Wenger; W J Casarella
Journal:  AJR Am J Roentgenol       Date:  1983-12       Impact factor: 3.959

6.  Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging.

Authors:  Kazuhiko Hashimoto; Takamichi Murakami; Keizo Dono; Masatoshi Hori; Tonsok Kim; Masayuki Kudo; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Hironobu Nakamura; Morito Monden
Journal:  Oncol Rep       Date:  2006-10       Impact factor: 3.906

7.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

8.  Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

Authors:  Christian Mölleken; Barbara Sitek; Corinna Henkel; Gereon Poschmann; Bence Sipos; Sebastian Wiese; Bettina Warscheid; Christoph Broelsch; Markus Reiser; Scott L Friedman; Ida Tornøe; Anders Schlosser; Günter Klöppel; Wolff Schmiegel; Helmut E Meyer; Uffe Holmskov; Kai Stühler
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

9.  MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis.

Authors:  Waldemar Hosch; Michael Bock; Martin Libicher; Sebastian Ley; Ute Hegenbart; Thomas J Dengler; Hugo A Katus; Hans-Ulrich Kauczor; Günter W Kauffmann; Arnt V Kristen
Journal:  Invest Radiol       Date:  2007-09       Impact factor: 6.016

Review 10.  Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease.

Authors:  Francesco Vizzutti; Umberto Arena; Valerio Nobili; Roberto Tarquini; Marco Trappoliere; Giacomo Laffi; Fabio Marra; Massimo Pinzani
Journal:  Ann Hepatol       Date:  2009 Apr-Jun       Impact factor: 2.400

View more
  42 in total

1.  Quantitative hepatic perfusion modeling using DCE-MRI with sequential breathholds.

Authors:  Eric M Bultman; Ethan K Brodsky; Debra E Horng; Pablo Irarrazaval; William R Schelman; Walter F Block; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

2.  MR elastography, T1 and T2 relaxometry of liver: role in noninvasive assessment of liver function and portal hypertension.

Authors:  David H Hoffman; Abimbola Ayoola; Dominik Nickel; Fei Han; Hersh Chandarana; James Babb; Krishna Prasad Shanbhogue
Journal:  Abdom Radiol (NY)       Date:  2020-09

3.  T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis.

Authors:  David H Hoffman; Abimbola Ayoola; Dominik Nickel; Fei Han; Hersh Chandarana; Krishna Prasad Shanbhogue
Journal:  Abdom Radiol (NY)       Date:  2020-03

4.  Measurement of T1 relaxation time of osteochondral specimens using VFA-SWIFT.

Authors:  Mikko J Nissi; Lauri J Lehto; Curtis A Corum; Djaudat Idiyatullin; Jutta M Ellermann; Olli H J Gröhn; Miika T Nieminen
Journal:  Magn Reson Med       Date:  2014-08-08       Impact factor: 4.668

5.  Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging.

Authors:  Jeong Hee Yoon; Jeong Min Lee; Munyoung Paek; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

6.  Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time 13C-methacetin breath test.

Authors:  Michael Haimerl; Irene Fuhrmann; Stefanie Poelsterl; Claudia Fellner; Marcel D Nickel; Kilian Weigand; Marc H Dahlke; Niklas Verloh; Christian Stroszczynski; Philipp Wiggermann
Journal:  Eur Radiol       Date:  2018-03-12       Impact factor: 5.315

7.  Quantitative assessment of disease severity of primary sclerosing cholangitis with T1 mapping and extracellular volume imaging.

Authors:  Sehnaz Evrimler; Jordan K Swensson; Vijay S Are; Temel Tirkes; Raj Vuppalanchi; Fatih Akisik
Journal:  Abdom Radiol (NY)       Date:  2020-11-01

Review 8.  Imaging of Hepatic Fibrosis.

Authors:  Rishi Philip Mathew; Sudhakar Kundapur Venkatesh
Journal:  Curr Gastroenterol Rep       Date:  2018-08-29

9.  Liver fat volume fraction quantification with fat and water T1 and T 2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T.

Authors:  Benjamin Leporq; Hélène Ratiney; Frank Pilleul; Olivier Beuf
Journal:  Eur Radiol       Date:  2013-04-16       Impact factor: 5.315

10.  T2 relaxation time is related to liver fibrosis severity.

Authors:  Alexander R Guimaraes; Luiz Siqueira; Ritika Uppal; Jamu Alford; Bryan C Fuchs; Suguru Yamada; Kenneth Tanabe; Raymond T Chung; Gregory Lauwers; Michael L Chew; Giles W Boland; Duhyant V Sahani; Mark Vangel; Peter F Hahn; Peter Caravan
Journal:  Quant Imaging Med Surg       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.